These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4120095)

  • 1. Immunological tolerance to a hapten. I. Induction and maintenance of tolerance to trinitrophenyl with trinitrobenzene sulfonic acid.
    Fidler JM; Golub ES
    J Exp Med; 1973 Jan; 137(1):42-54. PubMed ID: 4120095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance to a hapten. II. Maintenance and escape of the tolerant state to TNP.
    Fidler JM; Golub ES
    J Immunol; 1973 Aug; 111(2):317-23. PubMed ID: 4541558
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic tolerance to a hapten. 3. Induction of tolerance to trinitrophenyl in B cells in various differentiation states.
    Fidler JM; Golub ES
    J Immunol; 1974 May; 112(5):1891-9. PubMed ID: 4594419
    [No Abstract]   [Full Text] [Related]  

  • 4. Carrier-determined tolerance in vitro.
    Galanaud P; Aldo-Benson M; Borel Y
    J Immunol; 1975 Jan; 114(1 Pt 1):141-4. PubMed ID: 46237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of second signals on the induction of B cell tolerance: failure of helper T cells to block tolerance induction.
    Cambier JC; Corley RB
    Eur J Immunol; 1981 Jul; 11(7):550-6. PubMed ID: 6169534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresponsiveness in hapten-specific cytotoxic lymphocytes. III. Influence of H-2 and non-H-2 gene loci on the in vitro trinitrophenyl-specific CTL response following either acute or chronic in vivo treatment with trinitrobenzene sulfonic acid.
    Butler LD; Miller SD; Claman HN; Chiller JM
    Cell Immunol; 1983 Feb; 76(1):94-104. PubMed ID: 6600981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of persistent administration of a hapten with a reactive group (TNBS) and mono-or divalent conjugates of hapten to molecules without other reactive groups on anti-TNP-LPS response.
    Tuset N; Gras J
    Allergol Immunopathol (Madr); 1987; 15(1):7-14. PubMed ID: 3496773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hapten-specific tolerance in mice. I. Induction with hapten-coupled syngeneic erythrocytes.
    Hamilton JA; Miller JF
    Eur J Immunol; 1974 Apr; 4(4):261-8. PubMed ID: 4604520
    [No Abstract]   [Full Text] [Related]  

  • 10. Carrier and hapten antibody-producing cells, in vitro. I. Cytokinetics.
    Pazdernik TL; Uyeki EM; Doull J
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):232-7. PubMed ID: 4589212
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro induction of specific unresponsiveness against the 2,4,6-trinitrophenyl determinant. I. The induction of unresponsiveness.
    Kettman J
    J Immunol; 1974 Mar; 112(3):1139-48. PubMed ID: 4590698
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular and humoral immune responses in mice. II. Effect of intraperitoneal or subcutaneous injection of carrier of anti-hapten antibody and delayed hypersensitivity responses.
    Tamura SI; Egashira Y
    Immunology; 1975 May; 28(5):909-24. PubMed ID: 1169220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective improvement of thymus and some T cell dysfunctions in NZB mice by in utero thymulin treatment.
    Quéré P; Dardenne M; Bach MA
    J Immunol; 1985 Aug; 135(2):1180-5. PubMed ID: 2409141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
    Couderc J; Bleux C; Birrien JL; Liacopoulos P
    Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten specific unresponsiveness in mice. I. Characteristics of unresponsiveness induced by 2,4,6-trinitrobenzene sulphonic acid.
    Huchet R; Grandjon D; Davies AJ
    Immunology; 1979 Mar; 36(3):595-605. PubMed ID: 86508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo primary response to 2,4,6-trinitrophenyl substituted erythrocytes.
    Pazdernik TL; Uyeki EM
    Immunology; 1973 May; 24(5):823-30. PubMed ID: 4577080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-trinitrophenyl (TNP) antibody response: suppression by anti-macrophage serum.
    Isa AM
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):163-72. PubMed ID: 4631198
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance induced by TNP-derivatized syngeneic erythrocytes: evidence for cooperation between hapten-specific T and hapten-specific B lymphocytes in the immune response.
    Moody CE; Innes JB; Siskind GW; Weksler ME
    J Immunol; 1978 Mar; 120(3):844-9. PubMed ID: 75928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific and nonspecific mediators of T cell/B cell cooperation. I. Evidence for their production by different T cells.
    Marrack PC; Kappler JW
    J Immunol; 1975 Mar; 114(3):1116-25. PubMed ID: 1089726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro initiated secondary anti-hapten response. 3. Separable roles of hapten and carrier in immune paralysis.
    Rittenberg MB; Bullock WW
    Immunochemistry; 1972 May; 9(5):491-504. PubMed ID: 4556426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.